Lupin Ltd - GSpiriva on a Healthy Growth Track, Headwinds Receding
This to result in $200-220 million sales on a quarterly basis. USFDA recently completed cGMP inspection of Dabhasa plant and zconcluded with no...
179 Views
Akums Drugs and Pharmaceuticals Pre-IPO - Profitable but Needs to Scale up More
Akums Drugs and Pharmaceuticals (0200361D IN) is looking to raise up to US$239m in its upcoming India IPO. In this note, we talk about the...
115 Views
LUPIN Ltd - Margins Guidance Increased
The company’s sales increased by 20.2% YoY to Rs 5,197 Cr, and the growth was majorly led by its US business of $212 (+0.5% Q0Q).
415 Views
LUPIN Ltd - Positive Outlook Backed by the Launch of Niche Products
The company’s sales were up 28.6% YoY at Rs 4,330 Cr, and the growth was majorily led by its India business (+9.8% YoY), EMEA (+19.6% YoY)
270 Views
Mankind Pharma Lock-Up - A US$1.1bn+ Lockup Release
The two pre-IPO investors have launched a block to sell around US$591m worth of Mankind Pharma shares. Since the lockup on the shares expired not...
589 Views